Dr. Adam Rodman

And the reason some of these things exist is that there can be very dangerous symptoms.

Yeah.

And this is so like completely out of the discourse of like autonomous AI agents.

There's really exciting stuff happening.

So the Mayo Clinic, there have been some great studies on breast cancer detection.

A lot of these algorithms have gotten so good that they're able to identify breast cancer better than, I shouldn't say better than people, but in a workflow that has a good detection rate.

And then in picking up like potentially cancerous polyps when you get a colonoscopy.

So there's a lot of exciting and really positive things that are coming.

And I mean, at the end of the day, we'll need to see how RedMod works in the real world and a trial.

But I'm really optimistic about that sort of technology.

Number two, I think that when you talk about AI drug discovery, the part of the pipeline that's so difficult is not necessarily the coming up with the new compounds.

It's running the clinical trials and getting it through the regulatory process, which can probably be sped up, but not as much as the discovery.

You know, if we get this right, there's so many people in the U.S.

who don't have access to a doctor, who don't have access to very basic medications, who can't control their diabetes because of lack of access.

And I'm really hopeful that if we do this wisely, we can get people more access to care, which...

I'm doing my knock on wood, hopefully will improve health outcomes.

So like all of this, I think the potential benefits are like less exciting.

They're getting people, more people the bread and butter and getting, you know, more people to have less heart attacks, more people to have less strokes, more people to get their cancer screening and not necessarily like, oh, we cure aging with some sort of new AI discovered CRISPR technology.

I mean, the biggest wonder drug of my career has been the GLP-1s, which I started using it when I was a resident.

So we had it for a really long time and we had to like repurpose the drug for diabetes.